In colon cancer, Nrf2 is overexpressed, and, by elevating the expression of as P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP), Nrf2 induces doxorubicin resistance by drug efflux [67]. Here, ABCG2 is linked to colonic neoplasm.